Question 1

What are the potential benefits of participating in this trial for my diabetic nephropathy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients clinical trial (NCT02251067). Contact the study team or your healthcare provider for specific answers.

Question 2

How does VPI-2690B compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients clinical trial (NCT02251067). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from VPI-2690B?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients clinical trial (NCT02251067). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients clinical trial (NCT02251067). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will I need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients clinical trial (NCT02251067). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients clinical trial (NCT02251067). Contact the study team or your healthcare provider for specific answers.

What this study is about